Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aerosols and devices.

M B Dolovich1, J B Fink

  • 1Faculty of Health Science, Department of Medicine, McMaster University, Hamilton, Ontario, Canada. mdolovic@fhs.csu.mcmaster.ca

Respiratory Care Clinics of North America
|August 23, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The knowledgeable analyst: an approach to structuring man-machine systems.

AFOSR TR. United States. Air Force. Office of Scientific Research·2014
Same author

Consensus statement: aerosols and delivery devices.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same author

Aerosol therapy in mechanically ventilated patients: recent advances and new techniques.

Seminars in respiratory and critical care medicine·2005
Same author

Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.

British journal of clinical pharmacology·2003
Same author

Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

British journal of clinical pharmacology·2003
Same author

Uptake of 18fluorodeoxyglucose in the cystic fibrosis lung: a measure of lung inflammation?

The European respiratory journal·2003
Same journal

Indirect calorimetry: relevance to patient outcome.

Respiratory care clinics of North America·2006
Same journal

Indirect calorimetry: applications in practice.

Respiratory care clinics of North America·2006
Same journal

Strategies to prevent aspiration-related pneumonia in tube-fed patients.

Respiratory care clinics of North America·2006
Same journal

Feeding the critically ill obese patient: the role of hypocaloric nutrition support.

Respiratory care clinics of North America·2006
Same journal

Nutrition support for the long-term ventilator-dependent patient.

Respiratory care clinics of North America·2006
Same journal

A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome.

Respiratory care clinics of North America·2006
See all related articles

Effective aerosol therapy requires drug delivery systems that provide sufficient respirable particles to the lungs with minimal side effects. Patients must easily use and maintain these devices for optimal clinical benefit.

Area of Science:

  • Pulmonary Drug Delivery
  • Biomedical Engineering
  • Respiratory Medicine

Background:

  • Aerosol therapy is crucial for treating respiratory diseases.
  • Optimizing drug delivery to the lungs is essential for therapeutic efficacy.
  • Current challenges include ensuring adequate drug deposition and minimizing systemic side effects.

Purpose of the Study:

  • To outline the critical factors for successful aerosol therapy.
  • To identify key characteristics of effective aerosol delivery systems.
  • To emphasize the importance of patient-centric design in aerosol devices.

Main Methods:

  • This study is a review of existing literature and principles of aerosol therapy.
  • It analyzes the physical and biological aspects of drug delivery via inhalation.

Related Experiment Videos

  • Key performance indicators for aerosol devices are discussed.

    • Main Results:

    • Successful aerosol therapy hinges on delivering sufficient respirable drug particles to the target lung sites.
    • Minimizing drug loss during delivery and reducing systemic side effects are critical.
    • Device usability, maintainability, and patient adherence are paramount for clinical success.

    Conclusions:

    • Aerosol therapy success is multifactorial, requiring optimized drug delivery, minimal side effects, and user-friendly devices.
    • Future advancements should focus on improving aerosol deposition and patient experience.
    • Effective aerosol systems translate directly to improved patient outcomes in respiratory care.